Literature DB >> 20093828

Automated regional citrate anticoagulation: technological barriers and possible solutions.

Balazs Szamosfalvi1, Stanley Frinak, Jerry Yee.   

Abstract

BACKGROUND: Large-scale adoption of regional citrate anticoagulation (RCA) is prevented by risks of the technique as practiced traditionally. Safe RCA protocols with automated delivery on customized dialysis systems are needed.
METHODS: We applied kinetic analysis of solute fluxes during RCA to design a protocol for sustained low-efficiency dialysis (SLED) for critically ill patients. We used a high-flux hemodialyzer, a zero-calcium (Ca) dialysate, a dialysis machine with online clearance and access recirculation monitoring, and a separate optical hematocrit (Hct) sensor. Flow rates were Q(B) = 200 ml/min for blood; Q(D) = 400 ml/min for dialysate, with Na = 140 mmol/l and HCO(3) = 32 mmol/l; Q(citrate) = 400 ml/h of acid citrate dextrose A; ultrafiltration as indicated. The Q(Ca) was infused into the return blood line, adjusted hourly based on online Hct and a <24-hour-old albumin level.
RESULTS: Using the SLED-RCA protocol in an anhepatic, ex vivo dialysis system, ionized Ca (iCa) was >1 mmol/l in the blood reservoir and <0.3 mmol/l in the blood circuit after citrate but before Ca infusion (Q(Ca)) with normal electrolyte composition of the blood returning to the reservoir. Clinically, SLED-RCA completely abrogated clotting, without adverse electrolyte effects. The Q(Ca) prediction algorithm maintained normal systemic iCa (0.95-1.4 mmol/l) in all patients. The high citrate extraction on the dialyzer prevented systemic citrate accumulation even in shock liver patients. Safety analysis shows that building a dialysis system for automated SLED-RCA is feasible.
CONCLUSION: Using predictive Q(Ca) dosing and integrating control of the infusion pumps with the dialysis machine, SLED-RCA can be near-automated today to provide a user-friendly and safe system. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20093828     DOI: 10.1159/000245648

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  9 in total

Review 1.  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.

Authors:  Enrico Fiaccadori; Valentina Pistolesi; Filippo Mariano; Elena Mancini; Giorgio Canepari; Paola Inguaggiato; Marco Pozzato; Santo Morabito
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

2.  Regional Citrate Anticoagulation Protocol for Patients with Presumed Absent Citrate Metabolism.

Authors:  Balazs Szamosfalvi; Vidhit Puri; Ryann Sohaney; Benjamin Wagner; Amy Riddle; Sharon Dickinson; Lena Napolitano; Michael Heung; David Humes; Lenar Yessayan
Journal:  Kidney360       Date:  2020-12-18

Review 3.  Regional citrate anticoagulation for RRTs in critically ill patients with AKI.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Enrico Fiaccadori
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 8.237

Review 4.  Anticoagulation strategies in extracorporeal circulatory devices in adult populations.

Authors:  Catherine Kato; Michael Oakes; Morris Kim; Anish Desai; Sven R Olson; Vikram Raghunathan; Joseph J Shatzel
Journal:  Eur J Haematol       Date:  2020-10-18       Impact factor: 2.997

5.  Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosis.

Authors:  Mourad M Alsabbagh; A Ahsan Ejaz; Daniel L Purich; Edward A Ross
Journal:  Clin Kidney J       Date:  2012-04-20

6.  Coordination dynamics and coordination mechanism of a new type of anticoagulant diethyl citrate with ca(2+) ions.

Authors:  Jin Han; Jun-Fa Xue; Meng Xu; Bao-Song Gui; Li Kuang; Jian-Ming Ouyang
Journal:  Bioinorg Chem Appl       Date:  2013-12-24       Impact factor: 7.778

7.  Calcium Mass Balance during Citrate Hemodialysis: A Randomized Controlled Trial Comparing Normal and Low Ionized Calcium Target Ranges.

Authors:  Jakob Gubensek; Alesa Orsag; Rafael Ponikvar; Jadranka Buturovic-Ponikvar
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

8.  Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis.

Authors:  Ilan Lenga; Wilma M Hopman; Adam J O'Connell; Francesca Hume; Charles C Y Wei
Journal:  BMC Nephrol       Date:  2019-12-05       Impact factor: 2.388

9.  Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.

Authors:  Heleen M Oudemans-van Straaten; Marlies Ostermann
Journal:  Crit Care       Date:  2012-12-07       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.